Contributions of IncretinIvo
User contributions·25 logged edits·page 1 of 1
Contributions by IncretinIvo, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 15,723 edits includes activity predating the current log.
- 17:22, 18 Jun 2026 (diff | hist) Incretin effect 7,358 ±0 expand §Quantification and measurement
- 23:35, 3 May 2026 (diff | hist) Glucagon-like peptide-1 12,294 ±0 fix significant figures — source gives fewer
- 18:36, 17 Jan 2026 (diff | hist) Syringe dead space 17,673 ±0 split overlong sentence
- 21:46, 25 Dec 2025 (diff | hist) Hubei Jianxiang Bioscience 11,936 +63 reorder sections to follow the class template
- 23:20, 24 Dec 2025 (diff | hist) Incretin effect 7,358 ±0 m tag [citation needed]
- 12:45, 4 Oct 2025 (diff | hist) Reconstitution calculator 8,369 ±0 m state the assay for the reference interval
- 06:51, 28 Sep 2025 (diff | hist) Karl Fischer titration 9,318 ±0 m copyedit
- 17:57, 19 Sep 2025 (diff | hist) Shanghai ERP Biotechnology 6,047 ±0 m ce
- 05:10, 18 Sep 2025 (diff | hist) Trial data comparison 6,523 ±0 expand §Why the estimand matters
- 21:04, 16 Sep 2025 (diff | hist) Incretin effect 7,358 +224 m update infobox
- 17:22, 11 Aug 2025 (diff | hist) Incretin effect 7,134 ±0 British spelling per PP:MOS
- 15:54, 19 Jul 2025 (diff | hist) Multi-dose vial 18,051 +1,490 attribute range as a review estimate per talk
- 10:42, 12 Jul 2025 (diff | hist) Enteroendocrine L cell 5,083 ±0 correct transposed digits
- 05:25, 6 Jul 2025 (diff | hist) Sangon Biotech 7,862 ±0 add category
- 10:39, 8 Jun 2025 (diff | hist) Glucose-dependent insulinotropic polypeptide 6,898 ±0 rm unsourced claim per PP:V
- 21:30, 13 May 2025 (diff | hist) Peptide stability table 4,135 ±0 m merge two short sections
- 07:41, 12 Apr 2025 (diff | hist) Xi'an Mokemei Biotechnology 2,368 ±0 British spelling per PP:MOS
- 21:03, 14 Feb 2025 (diff | hist) Shanghai Wibson Biotechnology 2,479 ±0 fix unit
- 08:16, 26 Dec 2024 (diff | hist) Glucagon-like peptide-1 9,944 ±0 ce per MOS
- 09:04, 28 Nov 2024 (diff | hist) ChinaPeptides 3,926 ±0 m fix significant figures — source gives fewer
- 01:54, 9 Nov 2024 (diff | hist) Glucagon-like peptide-1 8,088 +202 m replace bare ref with full citation
- 08:02, 12 Oct 2024 (diff | hist) Incretin effect 4,803 +754 link to the policy rather than restating it
- 04:51, 5 Sep 2024 (diff | hist) Glucose-dependent insulinotropic polypeptide 4,346 ±0 m add category
- 13:40, 3 Sep 2024 (diff | hist) Talk:Glucagon-like peptide-1 611 +184 /* Residue numbering — (7–36) versus (1–30) */ reply
- 21:03, 11 Aug 2024 (diff | hist) Glucose-dependent insulinotropic polypeptide 3,409 +41 restructure